Keybanc Maintains Overweight on National Health Investors, Raises Price Target to $88

Benzinga · 1d ago
Keybanc analyst Todd M. Thomas maintains National Health Investors (NYSE:NHI) with a Overweight and raises the price target from $80 to $88.